Advent Pharma (DHA:ADVENT) Current Deferred Revenue: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ADVENT Advent Pharma Ltd DHA:ADVENT
32 GF Score
Price BDT16.10
View Full Analysis

What is Advent Pharma Current Deferred Revenue?

Advent Pharma DHA:ADVENT 32 Current Deferred Revenue is BDT0.00 Mil as of . 20. GuruFocus rates DHA:ADVENT with a GF Score™ of 32/100.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Advent Pharma's current deferred revenue for the quarter that ended in . 20 was BDT0.00 Mil.

Advent Pharma Current Deferred Revenue Related Terms

Advent Pharma Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Advent Pharma's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma Current Deferred Revenue Chart

Advent Pharma Annual Data
Trend
Current Deferred Revenue

Advent Pharma Semi-Annual Data
Current Deferred Revenue
DHA:ADVENT
32GF Score
Advent Pharma Ltd DHA:ADVENT
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of BDT0.00 Mil mean?
Advent Pharma (DHA:ADVENT) has a Current Deferred Revenue of BDT0.00 Mil as of . 20. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Advent Pharma and its competitors.
Is Advent Pharma's Current Deferred Revenue too high?
Advent Pharma's current Current Deferred Revenue is BDT0.00 Mil. Overall, Advent Pharma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's Current Deferred Revenue compare to ?
Advent Pharma's Current Deferred Revenue of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Drug Manufacturers company?
A good Current Deferred Revenue depends on the Drug Manufacturers industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Advent Pharma and its competitors. Advent Pharma's current Current Deferred Revenue is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current Current Deferred Revenue of BDT0.00 Mil. The current Current Deferred Revenue is BDT0.00 Mil. Advent Pharma's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current Current Deferred Revenue is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advent Pharma Business Description

Comparable Companies
Address Kakrail V.I.P. Road, Level no. 10, 80, Rupayan Karim Tower, Kakrail, Ramna, Dhaka, BGD, 1000
Advent Pharma Ltd is a Bangladesh-based company engaged in producing animal healthcare drugs and nutritional supplements for livestock.
32GF Score

Get the complete analysis for DHA:ADVENT

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT16.10
Price